MMR-varicella zoster virus vaccine - Merck Sharp & Dohme
Alternative Names: MMR/Varivax; ProQuadLatest Information Update: 05 Nov 2023
At a glance
- Originator Merck Sharp & Dohme
- Developer Merck & Co; Merck Sharp & Dohme
- Class Measles vaccines; Mumps vaccines; Rubella vaccines; Varicella vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Measles; Mumps; Rubella; Varicella zoster virus infections